Tabula Rasa HealthCare (NASDAQ:TRHC) reported Q2 EPS of ($0.53) from continuing operations, $0.32 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $68.31 million.
Tabula Rasa HealthCare (NASDAQ:TRHC) reported Q2 EPS of ($0.53) from continuing operations, $0.32 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $68.31 million.